论文部分内容阅读
望春花(600645) 利润主要得益于投资收益 总股本(万):15626.75 流通A股(万):6134.71 主营:平绒系列产品及制品,丝绒等 年报评析:虽然望春花主营的平绒系列产品及其制品,丝绒和印染布等纺织品业务并没有多大改善,但去年净利润却比99年增长了1.38倍,实在是令人吃惊。其实细看年报就可以发现,利润的大幅增长主要得益于三部分投资收益:1、股票投资收益1155万元;2、转让望春花宾馆获得投资收益1229万元;3、承德祥业路桥建设有限公司收益3200万元。 重大事项:去年望春花重拳出击基因生物制药(以干细胞为
Wang Chunhua (600645) profit mainly due to the return on investment Total capital (million): 15626.75 Circulation A shares (million): 6134.71 Main: velveteen products and products, velvet and other annual report Comments: Although the main Chunhua velveteen products And its products, velvet and printing and dyeing fabrics and other textile business did not improve much, but last year’s net profit was an increase of 1.38 times 99 years, it is really surprising. In fact, look at the annual report can be found, a substantial increase in profits mainly due to three parts of the investment income: 1, the stock investment income 11.55 million yuan; 2, Wang Chunhua Hotel transfer investment income of 12.29 million yuan; 3, Chengde Xiang Road and Bridge Construction Limited income 32 million yuan. Major issues: Last year, Chunhua spent a heavy blow to genetically modified organisms (stem cells for